Article
Large-scale study of the -232C > G polymorphism of PCK1 in Type 2 diabetes.
Diabetic medicine : a journal of the British Diabetic Association - 1 Oct 2006
Wegner L, Andersen G, Albrechtsen A, Sparsø T, Glümer C, Borch-Johnsen K, Jørgensen T, Hansen T, Pedersen O
Abstract excerpt
AIMS: Phosphoenolpyruvate carboxykinase (PEPCK) is a catalyst of the rate-limiting step in the gluconeogenic pathway and is regulated at the transcriptional level predominantly by insulin, glucocorticoids, glucagon, and cAMP. The -232C > G polymorphism in the gene encoding PEPCK (PCK1) is reported to associate with Type 2 diabetes in Canadian Caucasians and Oji-Cree populations. We have estimated the impact of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
